PAH

PAH (phenylalanine hydroxylase; HGNC:8582, NCBI Gene 5053) is the gene on chromosome 12q23.2 encoding phenylalanine hydroxylase — the liver enzyme that hydroxylates phenylalanine to tyrosine (with tetrahydrobiopterin as cofactor): the phenylketonuria (PKU) gene, whose recessive loss causes the classic inborn error of metabolism that newborn screening was invented to catch.

Approved Symbol
PAH (HGNC:8582)
Chromosomal Locus
12q23.2
Encoded Product
PAH — a 52-kDa tetrameric iron enzyme (452 aa/monomer)
Primary Pathway
Phenylalanine + BH4 + O2 → tyrosine (the phenylalanine catabolism gate)
Clinical / Therapeutic Role
Phenylketonuria (classic PKU); newborn screening; sapropterin BH4-responsive variants

Gene Structure & Expression

Molecular Function & Pathways

  • The catabolic gate: PAH's hydroxylation the sole route clearing dietary phenylalanine to tyrosine — loss accumulating phenylalanine (neurotoxic in development) while tyrosine becomes conditionally essential; the metabolic logic behind the phenylalanine-restricted diet, phenylalanine.
  • Genotype spectrum: Null variants the severe classic PKU; missense variants spanning mild hyperphenylalaninemia; some variants BH4-responsive (sapropterin the pharmacological chaperone restoring activity — precision therapy from genotype).

Clinical & Therapeutic Significance

  • PKU: Autosomal recessive; untreated severe variants causing intellectual disability — newborn screening (the Guthrie card) and the phenylalanine-restricted diet preventing it; the first population-screening program in metabolic medicine.
  • Therapeutics: Sapropterin (BH4) for responsive genotypes; pegvaliase (PEGylated phenylalanine ammonia-lyase) degrading phenylalanine for adults — the enzyme-substitution route; large-neutral-amino-acid supplements the adjunct.

Interacting Systems & Components

Sources

HGNC Gene Record

Approved Symbol
PAH
Approved Name
phenylalanine hydroxylase
Chromosomal Locus
12q23.2
HGNC Authority
HGNC:8582